N@N

KaloBios to Present at Future Leaders in the Biotech Industry Conference

^{Published on 2013-04-01 13:15:50 - Market Wire}
 

KaloBios to Present at Future Leaders in the Biotech Industry... -- SOUTH SAN FRANCISCO, Calif., April 1, 2013 /PRNewswire/ --

[ ]

[ Download image ]

SOUTH SAN FRANCISCO, Calif., April 1, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals (Nasdaq: KBIO) today announced that the company has been selected to present at the 2013 BioCentury-Thomson Reuters Future Leaders in the Biotech Industry Conference, to be held in New York City on April 5, 2013. KaloBios President and Chief Executive Officer, David W. Pritchard , will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.

(Logo: [ http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ])

Company Presentation:
When: Friday, April 5, 2013, 9:00 am EDT, Presentation Room 311
Where: Millennium Broadway Hotel and Conference Center, New York, NY

Webcast:
To access the live and archived audio webcast of the KaloBios Future Leaders presentation please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: [ http://ir.kalobios.com/events.cfm ].

A replay of the webcast will be available one hour after the conclusion of the live event. 

About KaloBios

KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat serious medical conditions with a primary clinical focus on respiratory diseases and cancer.  For more information on KaloBios Pharmaceuticals, please visit our web site at [ http://www.kalobios.com ].

Contact:

Jeffrey H. Cooper
Chief Financial Officer
KaloBios Pharmaceuticals, Inc.
(650) 243-3146
[ ir@kalobios.com ]

Media Contact:

Joan E. Kureczka
Kureczka/Martin Associates
Tel:  (415) 821-2413
Mobile: (415) 690-0210
[ Joan@Kureczka-Martin.com ]

SOURCE KaloBios Pharmaceuticals, Inc.